Main > A1. CORP. INDEX. Un-Uz > University British Columbia/P C2 > 2004. 01.18.2004. (Enzyme..)

Product Canada. U

STRUCTURE Nature Structural & Molecular Biology 11, 163 - 170 (2004)
Published online: 18 January 2004 | doi:10.1038/nsmb720
Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog
Cecilia P C Chiu1, Andrew G Watts2, 4, Luke L Lairson2, 4, Michel Gilbert3, Daniel Lim1, Warren W Wakarchuk3, Stephen G Withers2 & Natalie C J Strynadka1
1 Department of Biochemistry and Molecular Biology, University of British Columbia, 2146 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada.

2 Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada.

3 Institute for Biological Sciences, National Research Council, Room 3157, 100 Sussex Drive, Ottawa, Ontario K1A OR6, Canada.

4 These authors contributed equally to this work.

Correspondence should be addressed to Natalie C J Strynadka natalie@byron.biochem.ubc.ca


Sialic acid terminates oligosaccharide chains on mammalian and microbial cell surfaces, playing critical roles in recognition and adherence. The enzymes that transfer the sialic acid moiety from cytidine-5'-monophospho-N-acetyl-neuraminic acid (CMP-NeuAc) to the terminal positions of these key glycoconjugates are known as sialyltransferases. Despite their important biological roles, little is understood about the mechanism or molecular structure of these membrane-associated enzymes. We report the first structure of a sialyltransferase, that of CstII from Campylobacter jejuni, a highly prevalent foodborne pathogen. Our structural, mutagenesis and kinetic data provide support for a novel mode of substrate binding and glycosyl transfer mechanism, including essential roles of a histidine (general base) and two tyrosine residues (coordination of the phosphate leaving group). This work provides a framework for understanding the activity of several sialyltransferases, from bacterial to human, and for the structure-based design of specific inhibitors.

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back